SPRY
ARS Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Richard E. Lowenthal
IPO Date
2020-12-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
ARS Pharmaceuticals, Inc.
CEO
Richard E. Lowenthal
IPO Date
2020-12-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US